ANTIMICROBIAL RESISTANCE CHARACTERISTIC OF PSEUDOMONAS AERUGINOSA STRAINS ISOLATED FROM INTERNAL MEDICINE WARDS OF MILITARY HOSPITAL 103

Văn An Nguyễn, Thị Hồng Ngọc Nguyễn

Main Article Content

Abstract

Objective: Study the antimicrobial resistance characteristic of Pseudomonas aeruginosa strains isolated from internal medicine wards of Military Hospital 103. Subject and methods: This cross-sectional study aimed to investigate the antimicrobial resistance features of P. aeruginosa strains isolated from internal medicine wards of Military Hospital 103 in 2020. Results: The total number of P. aeruginosa strains isolated in 2020 was 109. Of which, P. aeruginosa was mostly isolated from male patients (68.8%), who were >60 years old (51.4%), the internal medicine intensive care unit (32.1%), and infectious diseases department (22.0%). P. aeruginosa was the most resistant to levofloxacin (66.4%), ciprofloxacin (66.1%), and ticarcillin/clavulanic acid (62.4%). By contrast, P. aeruginosa was the least resistant to colistin (5.3%). P. aeruginosa was the most sensitive to amikacin (57.8%) and the least sensitive to levofloxacin (31.8%). Conclusion: Our study indicated that P. aeruginosa was mostly isolated from the internal medicine intensive care unit and patients >60 years old. P. aeruginosa was the most resistant to levofloxacin, ciprofoxacin, and ticarcillin/clavulanic and the least resistant to colistin. P. aeruginosa was the most sensitive to amikacin and the least resistant to levofloxacin. 

Article Details

References

X. Y. Li, et al., The Distribution, Drug Susceptibility, and Dynamic Trends of Pseudomonas aeruginosa Infection in a Tertiary Hospital in China During 2016‒2022. Infect Drug Resist (2023). 16, 3525-3533.
2. S. Shbaita, et al., Antibiotic resistance profiles and associated factors of Pseudomonas Infections among patients admitted to large tertiary care hospital from a developing country. Antimicrob Resist Infect Control (2023). 12(1), 149.
3. J. Reyes, et al., Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe (2023). 4(3), e159-e170.
4. T. A. Hafiz, et al., Epidemiological, Microbiological, and Clinical Characteristics of Multi-Resistant Pseudomonas aeruginosa Isolates in King Fahad Medical City, Riyadh, Saudi Arabia. Trop Med Infect Dis (2023). 8(4).
5. Amy L. Leber, Clinical Microbiology Procedures Handbook, . 2016: ASM Press.
6. Clinical and Laboratory Standards Institute (CLSI), Performance Standards for Antimicrobial Susceptibility Testing 30rd ed. CLSI supplement M100. (2020).
7. Dương Quang Hiệp Lê Văn Cường, Sự phân bố và tính kháng thuốc của Trực khuẩn mủ xanh tại Bệnh viện đa khoa tỉnh Thanh Hóa năm 2020. Tạp chí Y học Việt Nam (2022). 511.
8. S. Araya, et al., Epidemiology and Multidrug Resistance of Pseudomonas aeruginosa and Acinetobacter baumanni Isolated from Clinical Samples in Ethiopia. Infect Drug Resist (2023). 16, 2765-2773.